Cargando…
Severe left ventricular systolic dysfunction in a patient with a typical haemolytic–uraemic syndrome treated with rituximab—coincidence or cause?
A 26-year-old female with haemolytic–uraemic syndrome (HUS) refractory to daily plasma exchange was successfully treated with rituximab. Subsequent testing confirmed the presence of mutations in genes encoding complement factor I and CD46. On Day 32 she developed pulmonary oedema, and echocardiograp...
Autores principales: | Petrie, Colin J., Weir, Robin A. P., Lindsay, Mitchell M., Padmanabhan, Neal, Douglas, Kenny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477969/ https://www.ncbi.nlm.nih.gov/pubmed/28657056 http://dx.doi.org/10.1093/ndtplus/sfq055 |
Ejemplares similares
-
Cutaneous involvement in haemolytic uraemic syndrome
por: Neild, G. H., et al.
Publicado: (2013) -
Sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: retrospective cohort study
por: Adams, Natalie, et al.
Publicado: (2019) -
Eculizumab and drug-induced haemolytic–uraemic syndrome
por: Faguer, Stanislas, et al.
Publicado: (2013) -
Eculizumab in secondary atypical haemolytic uraemic syndrome
por: Cavero, Teresa, et al.
Publicado: (2017) -
The haemolytic-uraemic syndrome. A report of two cases.
por: Field, C. M., et al.
Publicado: (1965)